PIK3CA and esophageal squamous cell carcinoma: IC50 value of cisplatin was negatively correlated with CACNA2D3 expression in ESCC cells, in the meantime, CACNA2D3 can enhance cisplatin sensitivity by inhibiting the PI3K/Akt pathway (56).